The US CDC quietly publishes a comment from Pfizer that they will not be manufacturing their August 2021 FDA approved [NDC] product called Comirnaty. The only product available to date in the US, including mandated for the military, has been the emergency use experimental product. [1]

They state they will make the formulation with the modified tris-sucrose ingredient, which was not part of the clinical trials conducted by Pfizer and thus a distinctly different product.